Biosimilar Product Information:FDA-Approved Biosimilar Products
FDA-Approved Biosimilar Products
Drug Name
|
Approval Date
|
More Information
|
|---|---|---|
| Herzuma (trastuzumab-pkrb) | December 2018 | Herzuma Information |
| Truxima (rituximab-abbs) | November 2018 | Truxima Information Press Release: FDA approves first biosimilar for treatment of adult patients with non-Hodgkin’s lymphoma |
| Udenyca (pegfilgrastim-cbqv) | November 2018 | Udenyca Information |
Hyrimoz
(adalimumab-adaz) |
October 2018
| Hyrimoz Information |
Nivestym
(filgrastim-aafi) |
July 2018
| Nivestym Information |
Fulphila
(pegfilgrastim-jmdb) |
June 2018
| |
Retacrit
(epoetin alfa-epbx) |
May 2018
| |
Ixifi
(infliximab-qbtx) |
December 2017
| |
Ogivri
(trastuzumab-dkst) |
December 2017
| |
Mvasi
(bevacizumab-awwb) |
September 2017
| |
Cyltezo
(adalimumab-adbm) |
August 2017
| |
Renflexis
(infliximab-abda) |
May 2017
| |
Amjevita
(adalimumab -atto) |
September 2016
| |
Erelzi (etanercept-szzs) |
August 2016
| |
Inflectra
(infliximab-dyyb) |
April 2016
| |
Zarxio
(filgrastim-sndz) |
March 2015
|
More info >>>FDA<<<<
